Literature DB >> 16076801

Treatment for otitis media.

Mathieu Lemaire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16076801      PMCID： PMC1180629          DOI： 10.1503/cmaj.1050050

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Hypotheses and type I error in active-control noninferiority trials.

Authors:  Gang Chen; Yong-Cheng Wang; George Y H Chi
Journal:  J Biopharm Stat       Date:  2004-05       Impact factor: 1.051

2.  Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.

Authors:  Mardi Gomberg-Maitland; Lars Frison; Jonathan L Halperin
Journal:  Am Heart J       Date:  2003-09       Impact factor: 4.749

3.  A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age.

Authors:  Nicole Le Saux; Isabelle Gaboury; Marian Baird; Terry P Klassen; Johnna MacCormick; Colline Blanchard; Carrol Pitters; Margaret Sampson; David Moher
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

4.  Trials to assess equivalence: the importance of rigorous methods.

Authors:  B Jones; P Jarvis; J A Lewis; A F Ebbutt
Journal:  BMJ       Date:  1996-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.